Skip to main content

Table 3 Clinical characteristics and laboratory findings in patients who developed SLE

From: Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia

N

At ITP diagnosis

At SLE diagnosis

Sex

Age

Organ bleeding

ANA

Platelet count (× 109/L)

Lymphocyte count (/μL)

Hemoglobin (g/dL)

ITP duration

Clinical features

ANA

Platelet count (× 109/L)

Lymphocyte count (/μL)

Hemoglobin (g/dL)

SLEDAI-2K

1

F

24

Vaginal bleeding

1:320 (S)

2

829

9.6

3 years

Arthritis, skin rash, fever, enteritis

1:1280 (H)

89

948

9.6

12

2

F

31

Vaginal bleeding

1:80 (S)

13

1289

12.8

19.4 years

Arthritis

1:1280 (H)

52

1305

11.6

9

3

F

32

-

 < 1:40

9

2033

11.1

5.5 years

Arthritis, skin rash, alopecia, Raynaud phenomenon

1:1280 (H)

192

493

11

12

4

F

52

Intracranial hemorrhage

1:40 (S)

13

2222

10.3

2.6 years

Arthritis, skin rash, alopecia

1:80 (N)

68

2478

12.2

11

5

F

48

-

1:40 (N)

5

557

11.1

1 year

Fever

1:80 (N)

43

1699

12.6

6

6

F

24

-

1:680 (S)

8

1726

12.4

1.8 years

Arthritis, skin rash, fever

1:1280 (S)

449

1500

8.9

13

7

F

39

Vaginal bleeding

1:160 (S)

11

475

10

2.3 year

Serositis, ascites

1:1280 (S)

48

610

12.5

5

8

F

18

-

1:320 (H)

11

1444

9.9

1.3 year

Arthritis, proteinuria

1:320 (H)

103

854

11.7

12

9

F

25

Vaginal bleeding

1:1280 (S)

3

1218

10.9

14.1 year

Arthritis

NA

36

1673

12.4

7

10

M

58

Hematochezia

1:320 (N)

17

397

10.8

1.2 year

Arthritis, fever, serositis

1:320 (N)

205

2220

15

7

  1. SLE systemic lupus erythematosus, ITP immune thrombocytopenia, N number, ANA antinuclear antibody, SLEDAI-2K SLE disease activity index 2000, F female, M male, (S) speckled type, (H) homogenous type, (N) nucleolar type, NA not available